• Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) Receives Average Recommendation of "Moderate Buy" from Analysts

    Source: Buzz FX / 09 Jan 2025 05:46:13   America/Chicago


    Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) Receives Average Recommendation of "Moderate Buy" from Analysts Written by MarketBeat January 9, 2025 Share Link copied to clipboard. Shares of Ultragenyx Pharmaceutical Inc.
    Read more...
Share on,